E
PBH icon

Ergoteles’s Prestige Consumer Healthcare PBH Stock Holding History

Ergoteles’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,958
Closed -$297K – 1774
2022
Q3 		$297K Buy
+5,958
New +$330K 0.01% 985
2021
Q3 		– Sell
-10,900
Closed -$568K – 1562
2021
Q2 		$568K Buy
+10,900
New +$524K 0.01% 748

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles's PBH Position: Q4 2022 in Review

Ergoteles sold out of Prestige Consumer Healthcare (PBH) in Q4 2022, closing a stake of 5,958 shares — an estimated $297K sold.

Ergoteles first reported a position in PBH in Q2 2021 and held it in 2 quarters. The position peaked at $568K in Q2 2021. 289 funds tracked by Wall St. Rank hold PBH as of Q4 2022.

  • Ergoteles reported no remaining Prestige Consumer Healthcare position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 5,958 Prestige Consumer Healthcare shares in Q4 2022, an estimated $297K.
  • Ergoteles first reported a position in Prestige Consumer Healthcare in Q2 2021 and held it in 2 quarters.
  • Ergoteles's Prestige Consumer Healthcare position peaked at $568K in Q2 2021.
  • 289 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.